Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones

Breast Cancer Research and Treatment

Volumn 115, Issue 2, 2009, Pages 279-287

  Potter, Shirley M ^a   Dwyer, Roisin M ^a   Curran, Catherine E ^a   Hennessy, Emer ^a   Harrington, Kate A ^a   Griffin, Damian G ^b   Kerin, Michael J ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Breast cancer; Menstrual hormones; Monocyte Chemotactic Protein 1 (MCP 1 CCL2); Prognosis; Stromal Cell derived Factor 1 (SDF 1 CXCL12)

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGESTERONE; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HORMONAL REGULATION; HUMAN; IMMUNOASSAY; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PREMENOPAUSE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; VOLUNTEER;

ADULT; BREAST NEOPLASMS; CHEMOKINE CCL2; CHEMOKINE CXCL12; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION; GONADAL HORMONES; HUMANS; LUTEINIZING HORMONE; MENSTRUAL CYCLE; MIDDLE AGED; PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 67349107150     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0078-2     Document Type: Article

References (38)

1. A Ben-Baruch 2003 Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions Breast Cancer Res 5 31 36 10.1186/bcr554
2. F Balkwill 2004 Cancer and the chemokine network Nat Rev Cancer 4 540 550 10.1038/nrc1388
3. H Kulbe NR Levinson F Balkwill 2004 The chemokine network in cancer-much more than directing cell movement Int J Dev Biol 48 489 496 10.1387/ijdb. 041814hk
4. LM McShane DG Altman W Sauerbrei 2006 REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 229 235 10.1007/s10549-006-9242-8
5. VS Rao CE Dyer JK Jameel 2006 Potential prognostic and therapeutic roles for cytokines in breast cancer Oncol Rep 15 179 185 Review
6. A Muller B Homey H Soto 2001 Involvement of chemokine receptors in breast cancer metastasis Nature 410 50 56 10.1038/35065016
7. Y Kang PM Siegel W Shu 2003 A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 537 549 10.1016/S1535-6108(03)00132-6
8. H Saji M Koike T Yamori 2001 Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma Cancer 92 1085 1091 10.1002/1097-0142(20010901)92:5 ≤ 1085::AID-CNCR1424 ≥ 3.0.CO;2-K
9. YM Li Y Pan Y Wei 2004 Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis Cancer Cell 6 459 469 10.1016/j.ccr.2004.09.027
10. JM Burns BC Summers Y Wang 2006 A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development J Exp Med 203 2201 2213 10.1084/jem.20052144
11. K Balabanian B Lagane S Infantino 2005 The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes J Biol Chem 280 35760 35766 10.1074/jbc.M508234200
12. A Orimo PB Gupta DC Sgroi 2005 Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 335 348 10.1016/j.cell.2005.02.034
13. N Cabioglu J Summy C Miller 2005 CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation Cancer Res 65 6493 6497 10.1158/0008-5472.CAN- 04-1303
14. S Hassan A Baccarelli O Salvucci 2008 Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer Clin Cancer Res 14 446 454 10.1158/1078-0432.CCR-07-1189
15. NA Bhowmick A Chytil D Plieth 2004 TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 303 848 851 10.1126/science.1090922
16. R Salcedo ML Ponce HA Young 2000 Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression Blood 96 34 40
17. E Neumark O Sagi-Assif B Shalmon 2003 Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors Int J Cancer 106 879 886 10.1002/ijc.11337
18. RM Dwyer SM Potter-Beirne KA Harrington 2007 Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells Clin Cancer Res 13 5020 5027 10.1158/1078-0432.CCR-07-0731
19. ZA Dehqanzada CE Storrer MT Hueman 2006 Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients Clin Cancer Res 12 478 486 10.1158/1078-0432.CCR-05-1425
20. A Lebrecht C Grimm T Lantzsch 2004 Monocyte chemoattractant protein-1 serum levels in patients with breast cancer Tumour Biol 25 14 17 10.1159/000077718
21. JM Hall KS Korach 2003 Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells Mol Endocrinol 17 792 803 10.1210/me.2002-0438
22. P Jilma-Stohlawetz M Homoncik C Drucker 2001 Fy phenotype and gender determine plasma levels of monocyte chemotactic protein Transfusion 41 378 381 10.1046/j.1537-2995.2001.41030378.x
23. K Heer H Kumar V Speirs 1998 Vascular endothelial growth factor in premenopausal women-indicator of the best time for breast cancer surgery? Br J Cancer 78 1203 1207
24. RM Dwyer SM Potter-Beirne KA Harrington 2007 Monocyte Chemotactic Protein-1 (MCP-1) secreted by primary breast tumors stimulates migration of Mesenchymal Stem Cells (MSCs) Clin Cancer Res 13 5020 5027 10.1158/1078-0432. CCR-07-0731
25. LJ Van't Veer H Dai MJ van de Vijver 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530 536 10.1038/415530a
26. JF Wang ZY Liu JE Groopman 1998 The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion Blood 92 756 764
27. AC Zannettino AN Farrugia A Kortesidis 2005 Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients Cancer Res 65 1700 1709 10.1158/0008-5472.CAN-04-1687
28. SK Martin AL Dewar AN Farrugia 2006 Tumor angiogenesis is associated with plasma levels of stromal-derived factor-1alpha in patients with multiple myeloma Clin Cancer Res 12 6973 6977 10.1158/1078-0432.CCR-06-0323
29. J Dimberg A Hugander S Lofgren 2007 Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients Int J Mol Med 19 11 15
30. MH Galea RW Blamey CE Elston 1992 The Nottingham Prognostic Index in primary breast cancer Breast Cancer Res Treat 22 207 219 10.1007/BF01840834
31. M Allinen R Beroukhim L Cai 2004 Molecular characterization of the tumor microenvironment in breast cancer Cancer Cell 6 17 32 10.1016/j.ccr.2004.06.010
32. H Kishimoto Z Wang P Bhat-Nakshatri 2005 The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12 Carcinogenesis 26 1706 1715 10.1093/carcin/bgi137
33. IM Holdaway BH Mason AE Lethaby 1997 Characteristics of the menstrual cycle at the time of surgery for breast cancer Br J Cancer 75 413 416
34. WJ Hrushesky AZ Bluming SA Gruber 1989 Menstrual influence on surgical cure of breast cancer Lancet 2 949 952 10.1016/S0140-6736(89)90956-2
35. RA Badwe WM Gregory MA Chaudary 1991 Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer Lancet 337 1261 1264 10.1016/0140-6736(91)92927-T
36. U Veronesi A Luini L Mariani 1994 Effect of menstrual phase on surgical treatment of breast cancer Lancet 343 1545 1547 10.1016/S0140-6736(94)92942-4
37. PE Mohr DY Wang WM Gregory 1996 Serum progesterone and prognosis in operable breast cancer Br J Cancer 73 1552 1555
38. RT Senie PP Rosen P Rhodes 1991 Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival Ann Intern Med 115 337 342